© 2000 American Heart Association, Inc.
Vascular Biology |
Periadventitial Inducible Nitric Oxide Synthase Expression and Intimal Thickening
From the Divisions of Pharmacology (G.R.Y.D.M., M.M.K., C.I.S., A.G.H., H.B.) and Cardiology (K.M.C.), University of Antwerp (UIA); and the Department of Pathology (M.M.K.), General Hospital Middelheim, Antwerp, Belgium.
Correspondence to Guido R.Y. De Meyer, Division of Pharmacology, University of Antwerp (UIA), Universiteitsplein 1, B-2610 Wilrijk, Belgium. E-mail gdemeyer{at}uia.ua.ac.be
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract—Positioning a silicone collar around the rabbit carotid artery induces a smooth muscle cell–rich intimal thickening. We investigated the localization of inducible nitric oxide synthase (iNOS) during thickening of the intima, the effect of iNOS inhibition on intimal thickness, and the effect of oxidized LDL (ox-LDL) on iNOS expression in the vessel wall. Collars were positioned for 18 hours or for 3, 7, or 14 days. Arterial cross sections were immunostained for iNOS, including naïve, sham-operated, and carotid arteries in which ox-LDL had been infused locally for 14 days. Furthermore, collars were connected to osmotic minipumps for local delivery (5 µL · h-1, 14 days, n=12) of saline or the iNOS inhibitor L-N6-(1-iminoethyl)-lysine-HCl (L-NIL, 10 mmol/L). In the adventitia and the periadventitial granulation tissue of collared arteries, iNOS-positive macrophages and T lymphocytes were present from 18 hours onward. The media and intima were negative for iNOS. Reverse transcription–polymerase chain reaction revealed iNOS mRNA in collared but not in sham-operated arteries. Local inhibition of iNOS doubled the intimal thickness and decreased nitrotyrosine staining. Ox-LDL–treated arteries, which had a thicker intima, showed a pronounced influx of macrophages and T lymphocytes in all layers of the vessel wall, accompanied by iNOS expression in a subpopulation of these cells. Our study indicates that iNOS was not induced in intimal thickenings predominantly consisting of smooth muscle cells. However, iNOS was expressed in (peri)adventitial tissue and counteracted the progression of intimal thickening. Ox-LDL treatment was accompanied by an abundant influx of iNOS-positive macrophages and T lymphocytes in the vessel, but this could not prevent the progression of intimal thickening.
Key Words: intima • oxidized LDL • nitric oxide • adventitia • local delivery
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Evidence in animals and humans indicates that atherosclerosis and intimal thickening, evoked by mechanical injury of the media, lead to the expression of inducible nitric oxide synthase (iNOS) in smooth muscle cells (SMCs) or macrophages within the arterial wall. Verbeuren et al1 provided functional evidence that nonendothelial NOS is induced in the aortas of hyperlipidemic rabbits. Further studies showed that in rabbits, iNOS was present in cholesterol-induced plaques in T lymphocytes,2 macrophages,2 3 and SMCs.3 Also in human plaques, iNOS was found in association with macrophages, SMCs, endothelial cells (ECs), and mesenchymal-appearing intimal cells3 4 5 6 but not in normal vessels. Furthermore, arterial SMCs in the neointima formed after a deendothelializing balloon injury to the rat carotid artery expressed iNOS.7 8 Also, balloon angioplasty led to the induction of NOS in non-ECs of the rabbit carotid artery.9
Positioning a silicone collar around the carotid artery of rabbits induces thickening of the intima.10 11 The collar model has the advantage that substances can be infused locally in the space between the collar and the arterial wall. Collar-induced intimal thickening is possibly the consequence of a combination of both vascular injury and hindrance of transmural flow by the collar, leading to retention of cytokines/growth factors within the segment enclosed by the collar.11 Although expression of iNOS can be induced by several cytokines,12 studies of the contractile behavior of isolated arteries have failed to demonstrate iNOS activity in the intima or media 14 days after collar placement. In contrast, a recent immunohistochemical study suggested abundant expression of iNOS in the intima of collared arteries.13
The aim of the present study was to investigate possible explanations for this clear-cut discrepancy. We studied whether iNOS is expressed after collar-induced intimal thickening, and if so, its localization (intima, media, and/or adventitia) and whether collar-induced intimal thickening is affected by local treatment with the selective iNOS inhibitor L-N6-(1-iminoethyl)-lysine-HCl (L-NIL). L-NIL is 1 of the most selective iNOS inhibitors that are currently available. It is 11-fold more selective for iNOS than for endothelial NOS (eNOS)14 and 5- to 28-fold14 15 more selective for iNOS than for neuronal NOS. Finally, in a retrospective study, iNOS expression was examined in intimal thickenings containing many monocytes and T lymphocytes in frozen tissue sections obtained from a previous study in which oxidized LDL (ox-LDL) was applied locally on the vessel wall.16
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Collar Implantation
Male New Zealand White rabbits (2.5 to 3 kg) were anesthetized with sodium pentobarbital (30 mg/kg IV). Both carotid arteries were surgically exposed and dissected from the surrounding tissues. In a first experiment, a flexible silicone collar (inlet/outlet diameter 1.8 mm, MED-4211 silicone; Nusil Technology) was positioned around the left carotid artery.11 The contralateral carotid artery was sham-operated; ie, it was isolated from the surrounding connective tissue and vagus nerve and was exposed to a similar stretch as the collared artery. The collar was left in position for 18 hours, 3 days, 7 days, or 14 days.
In a second experiment, a silicone collar was placed around each
carotid artery. The space (
100 µL) between the inner collar
wall and the outer wall of the left carotid artery was connected to an
osmotic minipump (Alzet 2 ML2, Alza Corp) by means of a sterile
polyethylene catheter (Intramedic PE60, Clay Adams polyethylene tubing;
Becton Dickinson). The minipump was placed subdermally in the thoracic
region and delivered either the vehicle (saline containing 2 µg/mL
polymyxin B at a rate of 5 µL/h, n=12 rabbits) or 10 mmol/L
L-NIL (Alexis Corp; 5 µL/h, n=12 rabbits) continuously and locally to
the carotid arteries for 14 days. Although the solutions were prepared
in a sterile manner, polymyxin B was present in all infusions to
bind possible traces of lipopolysaccharide.16 17
The collar around the right carotid artery was not connected to an
osmotic minipump. All rabbits were fed a normal diet and had ad libitum
access to tap water.
In a third, retrospective study, the frozen material obtained after perivascular infusion of ox-LDL for 2 weeks16 was stained for the presence of iNOS.
Preparation of Ox-LDL
LDL (Sigma, 4 mg protein per mL of PBS) was incubated with
6.4 µmol/L CuCl2 for 16 hours at 37°C.
After stopping the reaction by addition of 200 µmol/L EDTA and
cooling on ice (1 hour), the Cu2+ ions were
removed by extensive dialysis (24 hours, 4°C) against EDTA-containing
PBS, and the solution was concentrated and sterile-filtered as
described.18
Blood Pressure Measurements
Blood pressure was measured 1 day before the rabbits were killed
by using a Statham P2310 pressure transducer connected to an HP 88058
carrier amplifier. For this purpose, the skin of the ear of the rabbits
was disinfected and sprayed with lidocaine (10% solution, Astra
Nobelpharma), and a 22-gauge cannula was inserted into the central ear
artery under translumination.
Immunohistochemistry
After 18 hours or 3, 7, or 14 days, the rabbits were humanely
killed with an overdose of sodium pentobarbital, and 2 segments (2 to
3 mm) were cut from both the collar-treated zone of the carotid
artery and the zone proximal to the collar (ie, sham-operated zone).
One collared and one sham-operated segment were fixed in 4% formalin
for 24 hours. Then the carotid segments were dehydrated before being
embedded in paraffin. A second segment (from both the collared and
sham-operated zone) was immediately embedded in OCT (Tissue-Tek),
frozen with LN2, and used for frozen sections. In
addition, in the 18-hour and 14-day groups, a third segment (from both
collared and sham-operated vessels) was snap-frozen in
LN2 and used for reverse
transcription–polymerase chain reaction (RT-PCR).
Staining for iNOS was done on both formalin-fixed and frozen sections. As primary antibodies, both a rabbit polyclonal (1:1000, Transduction Laboratories) and a mouse monoclonal (1:500, Transduction Laboratories) antibody were used. The secondary antibodies were, respectively, goat anti-rabbit (1:200, Vector Laboratories) and horse anti-mouse (1:200, Vector Laboratories). In addition, naïve and sham-operated carotid arteries and the carotid artery specimens obtained in a previous experiment, in which ox-LDL (oxidized with Cu2+ at 7 µg/h) had been infused locally into the interior of the collar for 14 days,16 were stained for iNOS. The primary antibodies were carefully titrated, and with every series of stainings, both negative (naïve carotid artery and omission of the primary antibody) and positive (granulation tissue after collaring and arteries from cholesterol-fed rabbits) controls were included. To confirm the in vivo activity of iNOS and the effect of L-NIL on NO production, we performed an immunohistochemical stain for nitrotyrosine (Upstate Biotechnology, Inc).19
Immunohistochemical detection of SMCs (
-SMC actin, clone 1A4; Sigma,
1:3 000 000) was done on both formalin-fixed and frozen preparations
and of macrophages (CD68, clone EBM11; Dako, 1:1000) and T
lymphocytes (CD43, clone L11/135; Dako, 1:300) on frozen preparations
by using specific monoclonal antibodies. The antibody to -SMC actin
was detected by an indirect peroxidase antibody conjugate technique.
The sections were incubated with a goat anti-mouse peroxidase antibody
(Jackson) for 45 minutes. The antibodies to CD68, CD43, nitrotyrosine,
and iNOS were detected with the ABC technique (avidin and biotinylated
horseradish peroxidase macromolecular complex; Vectastain ABC kit,
Vector Laboratories). 3-Amino-9-ethylcarbazole (AEC) was used as a
chromogen.
In addition, double-labeling immunohistochemistry was performed to
detect colocalizations of iNOS and CD68, iNOS and -SMC actin, and
iNOS and CD43. The antibodies were detected by using the Vectastain ABC
kit. For iNOS, a peroxidase-coupled complex was applied, and
diaminobenzidine (DAB, Sigma) served as a chromogen. For the other
antibodies, an alkaline phosphatase–coupled complex was used with fast
blue BB (Sigma) as the chromogen.
RNA Extraction and RT-PCR Analysis
Total RNA was isolated by the guanidinium isothiocyanate and
phenol/chloroform extraction method.20 RT-PCR was
performed with an automatic thermal cycler (Mastercycler gradient,
Eppendorf) and the ThermoScript 2-step RT-PCR system (Life
Technologies). After denaturation of RNA and primer at 65°C for 5
minutes, reverse transcription was performed at 50°C for 60 minutes,
followed by 85°C for 5 minutes. The final concentrations in the cDNA
synthesis mixture (20 µL) were as follows: 3 µg total RNA; 2.5
µmol/L oligo(dT)20 primer; 5 mmol/L DTT;
40 U RNase inhibitor; 1 mmol/L dNTP mix; and 15 U
ThermoScript reverse transcriptase. For the PCR step, the following
specific primers were used: (1) rabbit iNOS mRNA sense (5'-GCT ACA CTT
CCA ACG CAA CAT-3'; GenBank accession No. OCU85094, positions 203 to
223) and rabbit iNOS mRNA antisense (5'-AAT CCA CAA CTC GCT CCA A-3';
GenBank accession No. OCU85094, positions 475 to 493). Rabbit ß-actin
mRNA sense (5'-GCG GCA CCA GGG CGT-3'; GenBank accession No. X60733,
positions 189 to 203) and rabbit ß-actin mRNA antisense (5'-ATG GCC
GGC GTG TTG AAC-3'; GenBank accession No. X60733, positions 453 to 470)
primers were used as controls.21 The final concentrations
in the PCR mixture (50 µL) were 1.82 mmol/L
MgCl2; 0.2 mmol/L dNTP mix; 0.2
µmol/L each sense and antisense primers; 2 U Platinum Taq
DNA polymerase; and 2 µL cDNA preparation. The thermocycling
parameters were as follows: denaturation of the template at
94°C for 2 minutes; 35 cycles consisting of incubations at 94°C for
30 seconds, 60°C for 1 minute, and 72°C for 30 seconds; followed by
a prolonged elongation time of 10 minutes at 72°C. Products were
analyzed by agarose (2%) gel electrophoresis and visualized by
ethidium bromide under UV light.
Intimal Thickness
The thickness of intima and media was measured using PC Image
Color software (Foster Findlay) by an observer who was unaware of the
treatment. From each artery 2 sections were analyzed and
averaged, after measuring intimal and medial thicknesses at 20 random
sites per section covering the whole ring.
Statistical Analysis
All data are expressed as mean±SEM; n refers to the number of
rabbits. Differences between the collared segment with and without
infusion were evaluated by Wilcoxon signed-rank test with a
significance level of 0.05.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Immunohistochemistry of iNOS
To reproduce a previously described experiment,13 we first used a rabbit polyclonal antiserum to iNOS on both formalin-fixed and frozen sections. To visualize this primary antibody, a donkey anti-rabbit IgG-peroxidase was used.13 There was strong immunoreactivity in the intima (Figure 1A
). However, omitting the primary
antibody (ie, using the secondary antibody alone) led to identical
results (Figure 1B). This finding had not been mentioned
previously.13 Sham-operated sections did not show any
staining in the absence or presence of the secondary antibody (results
not shown).
|
Therefore, we subsequently used a monoclonal antibody to iNOS on frozen
sections from naïve, sham-operated, and collared carotid
arteries. In naïve carotid arteries (Figure 2A) and sham-operated arteries (Figure
2B), iNOS was not detectable. After collaring of the carotid
artery for 18 hours (Figure 2C) and 3 days (Figure 2D),
there was a faint signal of iNOS immunoreactivity in the adventitia.
After 7 days, immunoreactivity for iNOS was very clearly demonstrable
in the adventitia and the periadventitial granulation tissue (Figure
2E). This staining pattern was similar after 14 days’ collaring
but was even more pronounced (Figures 2F through 2H).
Immunoreactivity for iNOS in the intima was completely absent (Figure
2G). Omitting the primary antibody resulted in the complete loss
of immunoreactivity (Figure 2I). The immunoreactivity of iNOS
after L-NIL treatment was similar to that in the segments without L-NIL
treatment (results not shown).
|
Double-labeling immunohistochemistry revealed colocalization with CD68
(Figure 2J) and CD43 (Figure 2L), indicating that iNOS
was present in macrophages and T lymphocytes, respectively.
In contrast, iNOS was not present in -SMC actin–positive cells
(Figure 2K).
In material obtained after local administration of ox-LDL, there was an
abundant influx of monocytes and T lymphocytes into the vessel wall,
and intimal hyperplasia was more pronounced.16 In this
case, iNOS was present, not only in the periadventitia and
adventitia but also in the media and the thick intima (Figures
2M and 2N). iNOS was localized in macrophages and T
lymphocytes but not in SMCs (Figures 2O through 2Q). There was
only a faint staining for iNOS in the ECs. The periadventitial staining
of iNOS was similar in arteries with or without ox-LDL treatment.
Immunohistochemistry of Nitrotyrosine
In the saline-treated collared segments, nitrotyrosine was
detected in the periadventitia (Figure 2R), which fits with the
presence of iNOS in macrophages and T lymphocytes in the
periadventitial granulation tissue after collaring. In contrast, after
local application of the iNOS inhibitor L-NIL (vide infra),
the signal for nitrotyrosine was significantly decreased or even
completely absent in the periadventitia (Figure 2S).
RT-PCR of iNOS mRNA
We studied the presence of iNOS mRNA in sham-operated and collared
arteries at both an early (18 hours) and a late (14 days) time point.
iNOS mRNA was detected in arteries that had been collared for 14 days
as the expected 291-bp amplified product. Omitting either the RNA
or the reverse transcription step did not result in a band on the gel
(data not shown). Sham-operated arteries were negative. The signal for
ß-actin mRNA (253 bp), which was used as an internal control, did not
differ between the sham-operated and collared arteries (Figure 3). Eighteen hours after collaring, iNOS
mRNA could not be detected (data not shown).
|
Effect of the iNOS Inhibitor L-NIL on Collar-Induced
Intimal Thickening: Stability of the Inhibitory Capacity
of L-NIL
To determine the stability of the inhibitory capacity
of L-NIL, its effect on nitrite production of stimulated
(lipopolysaccharide plus interferon-
) J774
macrophages in culture was determined. There was no difference
in the inhibitory capacity between a fresh solution of
L-NIL and a solution that had been stored in osmotic minipumps placed
in an incubator at 37°C for 14 days (data not shown).
Body Weight and Blood Pressure
There was no significant difference in body weight among the
3 treatment groups: 2.65±0.13 kg in the saline group; 2.68±0.15 kg in
the L-NIL group at the start of the experiment; and 2.95±0.17 and
2.92±0.14 kg for the respective groups after 14 days of treatment. Two
weeks of local treatment with L-NIL did not alter mean
arterial blood pressure: 86±3 mm Hg in the saline
group and 84±3 mm Hg in the L-NIL group.
Thickness of the Intima
Sham-operated segments proximal to the collar did not develop
intimal thickening. After positioning a silicone collar around the
carotid artery, intimal thickening was induced. Local delivery of
saline did not increase intimal thickness compared with that in the
contralateral artery, which had been surrounded by a collar not
connected to a minipump (Figure 4). Local
delivery of L-NIL doubled intimal thickening compared with the
contralateral collared artery (Figure 4). Infusion of saline
induced a small increase in medial thickness (132±4 versus 110±6
µm; P<0.05, n=12 arteries, measured in duplicate). L-NIL
had no effect on the thickness of the media.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Annoying problems with the specificity of iNOS immunostains have recently been reported.22 The main conclusion was that it is essential to include appropriate controls for the species studied, and if possible, to confirm the immunostaining by another technique such as RT-PCR. Hence, we carefully controlled our iNOS immunostains by using appropriate negative (naïve rabbit carotid artery and omission of the primary antibody) and positive controls as well as RT-PCR.
Previously, the presence of iNOS in the intimal thickening induced by a periarterial collar in the rabbit carotid artery had been reported.13 In that study, a rabbit polyclonal iNOS antiserum (primary antibody) and a donkey anti-rabbit IgG-peroxidase (secondary antibody) were used. However, we found that omitting the primary antibody yielded an identical result. Inthe absence of the primary antibody, the immunoreactivity in the intima can be explained by reaction of the secondary antibody with IgG that has infiltrated into the intima of the collared but not the sham-operated arteries. Indeed, a drastic increase in the permeability of collared arteries for macromolecules such as fibrinogen has been reported,23 24 although the EC layer remains present in this model.10
Furthermore, in that study, it had also been reported that carotid arteries that had been collared for 7 days, but not control arteries, produced an increase in resting tone after addition of NG-nitro-L-arginine (10-5 mol/L), suggesting a higher basal release of NO in collared arterial segments than in controls.13 This confirmed our previous study,25 which demonstrated that NG-nitro-L-arginine (2x10-5 mol/L) increased the contraction to KCl in collared arteries. However, this effect was seen only when ECs were present.25 The discrepancy between these 2 studies may be explained not only by the absence or presence of ECs but also by the differences in the presence of remnants of periadventitial granulation tissue on the ring segments in the organ chambers.
By using a monoclonal antibody to iNOS on frozen sections of collared arteries, we demonstrated that iNOS was present in the adventitia and the periadventitial granulation tissue surrounding collared arteries, which became very pronounced after 7 and 14 days. Double-labeling immunohistochemistry revealed the presence of iNOS in macrophages and T lymphocytes. However, we failed to detect iNOS immunoreactivity in the intima after 18 hours, 3 days, 7 days, or 14 days of collaring.
Taken together, our study indicates that in collar-induced intimal thickening, which predominantly consists of SMCs, iNOS is induced in the (peri)adventitial tissue. Moreover, the immunostain for nitrotyrosine,19 which is considered a footprint of the formation of peroxynitrite, proved that the iNOS protein displayed enzyme activity. The intimal or medial SMCs were not the main iNOS-expressing cell type in the injured artery, in contrast to findings by others in the balloon-denuded rat carotid artery.8 Because various cytokines such as interleukins-1 and -2 have been shown to be powerful stimulators of iNOS gene expression,12 the induction of iNOS in the (peri)adventitia may be caused by the retention of cytokines in the collared region.11
In addition, we showed that the presence of iNOS in the adventitia and periadventitial granulation tissue has functional consequences: blocking the (peri)adventitial iNOS strongly reduced the formation of nitrotyrosine residues and doubled the intimal thickness. The observation that the modest nitrotyrosine formation in ECs was not affected by L-NIL infusion points to selective inhibition of iNOS compared with eNOS. Therefore, NO formed by (peri)adventitial iNOS may be, at least in part, responsible for the fact that the thickening of the intima induced by the collar does not increase further after 14 days,10 ie, when iNOS expression became very pronounced. This fits with the concept that the adventitial response to arterial injury may be an important determinant of restenosis by influencing intimal thickening as well as remodeling.26
Fourteen days of local treatment with L-NIL had no effect on the mean
arterial blood pressure. This is not surprising, because
the drug was infused locally in relatively small amounts. Even if all
the material had reached the systemic circulation, the dose
(6x10-8 g/kg body weight per minute) was still
10 000 times less than the ED50 of L-NIL for
elevation of blood pressure.14 The immunoreactivity of
iNOS after L-NIL treatment was similar to the segments without L-NIL
treatment. Also, in a model of acute peritonitis in rats, L-NIL
dramatically reduced NO levels without significantly affecting iNOS
protein levels.27 Furthermore, L-NIL inhibits
cytokine-induced NO production without affecting
iNOS mRNA.28
Our findings indicate that local inhibition of intimal thickening may be explained via interaction with iNOS-producing (peri)adventitial cells. We and others previously reported that supplementation with an NO donor reduced collar-induced intimal thickening.29 30 31 Furthermore, eNOS gene transfer32 33 as well as iNOS gene transfer34 inhibited intimal hyperplasia. NO generated from iNOS may prevent intimal thickening by inhibition of mitosis35 or migration29 32 of vascular SMCs, maintenance of the endothelial barrier function,36 or stimulation of EC regeneration.37 The latter possibility seems less likely. Because early detachment of ECs is very limited in the collar model, EC loss is not related to intimal hyperplasia, and full regeneration is already complete at 24 hours,10 ie, at a time when iNOS mRNA and protein were not yet expressed.
Despite the observation that local ox-LDL treatment was accompanied by
an abundant influx of iNOS-positive macrophages and T
lymphocytes in the vessel, intimal thickness was increased. Several
explanations are conceivable for this observation. First, the increased
iNOS expression may lead to local levels of NO that may become
detrimental. Second, the stimuli for intimal thickening evoked by
ox-LDL may be too strong to be overcome by NO produced from iNOS.
Third, the intimal thickening induced by collaring alone was mainly
composed of -SMC actin–immunoreactive cells, in contrast with the
intimal thickening evoked by ox-LDL exposure, which showed an
inhomogeneous expression of -SMC actin but produced
large amounts of collagen.16 Possibly, NO generated from
iNOS has only an inhibitory effect on SMC proliferation
and/or migration but not on collagen production.
In summary, in collar-induced intimal thickening, which predominantly consists of SMCs, iNOS is induced in (peri)-adventitial tissue but not in the intima. Blocking iNOS in the periadventitia doubles intimal thickness. Hence, we have presented evidence that adventitial iNOS counteracts the progression of intimal thickening, which may be relevant in maintaining arterial patency. In contrast, in intimal thickening, in which many inflammatory cells were elicited by local application of ox-LDL, the expression of iNOS was clearly detectable in the intima, media, adventitia, and periadventitia. Under these conditions, iNOS expression could not prevent progression of intimal thickening.
|
Acknowledgments |
|---|
The financial support of the Bekales Foundation (Bekales Research Grant and Bekales Prize 1998), the GOA (concerted action University of Antwerp), and the FWO Levenslijn project 7.0014.98 is greatly appreciated. Dr De Meyer is a research associate and Dr Kockx, a recipient of a fund for fundamental clinical research of the Fund for Scientific Research, Flanders, Belgium. The authors acknowledge the assistance of Martine De Bie, Hermine Fret, François Jordaens, and Rita Van Den Bossche and thank Dr Katelijne Matthys and Cor Van Hove for the supply of the ox-LDL–treated carotid artery specimens.
Received July 27, 1999; accepted February 15, 2000.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Verbeuren TJ, Bonhomme E, Laubie M, Simonet S. Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1993;21:841–845.[Medline] [Order article via Infotrieve]
2. Esaki T, Hayashi T, Muto E, Yamada K, Kuzuya M, Iguchi A. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis. 1997;128:39–46.[Medline] [Order article via Infotrieve]
3.
Luoma JS, Stralin P, Marklund SL, Hiltunen TP,
Sarkioja T, Ylä-Herttuala S. Expression of extracellular SOD and
iNOS in macrophages and smooth muscle cells in human and rabbit
atherosclerotic lesions: colocalization with epitopes characteristic of
oxidized LDL and peroxynitrite-modified proteins. Arterioscler
Thromb Vasc Biol. 1998;18:157–167.
4. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77–85.[Medline] [Order article via Infotrieve]
5. Akyurek LM, Fellstrom BC, Yan ZQ, Hansson GK, Funa K, Larsson E. Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. Am J Pathol. 1996;149:1981–1990.[Abstract]
6.
Wilcox JN, Subramanian RR, Sundell CL, Tracey WR,
Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of
nitric oxide synthase in normal and atherosclerotic vessels.
Arterioscler Thromb Vasc Biol. 1997;17:2479–2488.
7.
Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm A,
Jennische E. Arterial smooth muscle cells express nitric
oxide synthase in response to endothelial injury.
J Exp Med. 1994;180:733–738.
8.
Yan Z, Hansson GK. Overexpression of inducible nitric
oxide synthase by neointimal smooth muscle cells.
Circ Res. 1998;82:21–29.
9. Bosmans JM, Bult H, Vrints CJ, Kockx MM, Herman AG. Balloon angioplasty and induction of non-endothelial nitric oxide synthase in rabbit carotid arteries. Eur J Pharmacol. 1996;310:163–174.[Medline] [Order article via Infotrieve]
10.
Kockx MM, De Meyer GRY, Andries LJ, Bult H, Jacob WA,
Herman AG. The endothelium during cuff-induced
neointima formation in the rabbit carotid artery.
Arterioscler Thromb. 1993;13:1874–1884.
11.
De Meyer GRY, Van Put DJM, Kockx MM, Van Schil P,
Bosmans R, Bult H, Buyssens N, Vanmaele R, Herman AG. Possible
mechanisms of collar-induced intimal thickening. Arterioscler
Thromb Vasc Biol. 1997;17:1924–1930.
12.
Stuehr DJ, Marletta MA. Induction of nitrite/nitrate
synthesis in murine macrophages by BCG infection, lymphokines,
or interferon-. J Immunol. 1987;139:518–525.[Abstract]
13.
Arthur JF, Yin ZL, Young HM, Dusting GJ. Induction
of nitric oxide synthase in the neointima induced by a
periarterial collar in rabbits. Arterioscler Thromb
Vasc Biol. 1997;17:737–740.
14. Faraci WS, Nagel AA, Verdries KA, Vincent LA, Xu H, Nichols LE, Labasi JM, Salter ED, Pettipher ER. 2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo. Br J Pharmacol. 1996;119:1101–1108.[Medline] [Order article via Infotrieve]
15. Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem. 1994;37:3886–3888.[Medline] [Order article via Infotrieve]
16.
Matthys KE, Van Hove CE, Kockx MM, Andries LJ, Van
Osselaer N, Herman AG, Bult H. Local application of LDL promotes
intimal thickening in the collared carotid artery of the rabbit.
Arterioscler Thromb Vasc Biol. 1997;17:2423–2429.
17. Warner SJ, Mitchell D, Savage N, McClain E. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B. Biochem Pharmacol. 1985;34:3995–3998.[Medline] [Order article via Infotrieve]
18. Matthys KE, Jorens PG, Marescau B, Rosseneu M, Bult H, Herman AG. Oxidized lipoproteins suppress nitric oxide synthase in macrophages: study of glucocorticoid receptor involvement. Mediators Inflamm. 1994;3:323–327.
19. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler. 1994;375:81–88.[Medline] [Order article via Infotrieve]
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159.[Medline] [Order article via Infotrieve]
21.
Harris DE, Warshaw DM, Periasamy M.
Nucleotide sequences of the rabbit -smooth-muscle
and ß-non-muscle actin mRNAs. Gene. 1992;112:265–266.[Medline]
[Order article via Infotrieve]
22.
Coers W, Timens W, Kempinga C, Klok PA, Moshage H.
Specificity of antibodies to nitric oxide synthase isoforms in human,
guinea pig, rat, and mouse tissues. J Histochem
Cytochem. 1998;46:1385–1391.
23. Coleman PJ, Lever MJ, Martin JF. Transarterial fibrinogen flux in the anaesthetized rabbit. J Physiol. 1993;467:41P. Abstract.
24.
Bosmans JM, Kockx MM, Vrints CJ, Bult H, De Meyer GRY,
Herman AG. Fibrin(ogen) and von Willebrand factor deposition
are associated with intimal thickening after balloon angioplasty of the
rabbit carotid artery. Arterioscler Thromb Vasc Biol. 1997;17:634–645.
25. De Meyer GRY, Bult H, Üstünes L, Kockx M, Jordaens FH, Zonnekeyn LL, Herman AG. Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery. Br J Pharmacol. 1994;112:471–476.[Medline] [Order article via Infotrieve]
26.
Bosmans JM, Vrints CJ, Kockx MM, Bult H, Cromheeke KM,
Herman AG. Continuous perivascular L-arginine delivery
increases total vessel area and reduces neointimal
thickening after experimental balloon dilatation. Arterioscler
Thromb Vasc Biol. 1999;19:767–776.
27. Cockrell A, Laroux FS, Jourd’heuil D, Kawachi S, Gray L, Van der Heyde H, Grisham MB. Role of inducible nitric oxide synthase in leukocyte extravasation in vivo. Biochem Biophys Res Commun. 1999;257:684–686.[Medline] [Order article via Infotrieve]
28. Li W, Xia J, Sun GY. Cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate. J Interferon Cytokine Res. 1999;19:121–127.[Medline] [Order article via Infotrieve]
29. De Meyer GRY, Bult H, Üstünes L, Kockx MM, Feelisch M, Herman AG. Effect of nitric oxide donors on neointima formation and vascular reactivity in the collared carotid artery of rabbits. J Cardiovasc Pharmacol. 1995;26:272–279.[Medline] [Order article via Infotrieve]
30. Yin ZL, Dusting GJ. A nitric oxide donor (spermine-nonoate) prevents the formation of neointima in rabbit carotid artery. Clin Exp Pharmacol Physiol. 1997;24:436–438.[Medline] [Order article via Infotrieve]
31. Yasa M, Kerry Z, Yetik G, Sevin G, Reel B, Özdemir N, Erhan Y, Üstünes L, Berkan T, Özer A. Effects of treatment with FK409, a nitric oxide donor, on collar-induced intimal thickening and vascular reactivity. Eur J Pharmacol. 1999;374:33–39.[Medline] [Order article via Infotrieve]
32.
von der Leyen HE, Gibbons GH, Morishita R, Lewis NP,
Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy
inhibiting neointimal vascular lesion: in vivo transfer of
endothelial cell nitric oxide synthase gene. Proc
Natl Acad Sci U S A. 1995;92:1137–1141.
33.
Janssens S, Flaherty D, Nong Z, Varenne O, van
Pelt N, Haustermans C, Zoldhelyi P, Gerard R, Collen D. Human
endothelial nitric oxide synthase gene transfer
inhibits vascular smooth muscle cell proliferation and
neointima formation after balloon injury in rats.
Circulation. 1998;97:1274–1281.
34. Shears LL 2nd, Kibbe MR, Murdock AD, Billiar TR, Lizonova A, Kovesdi I, Watkins SC, Tzeng E. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg. 1998;187:295–306.[Medline] [Order article via Infotrieve]
35. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774–1777.
36.
Forster BA, Weinberg PD. Changes with age in the
influence of endogenous nitric oxide on transport
properties of the rabbit aortic wall near branches. Arterioscler
Thromb Vasc Biol. 1997;17:1361–1368.
37. Tzeng E, Kim YM, Pitt BR, Lizonova A, Kovesdi I, Billiar TR. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery. 1997;122:255–263.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  V. Croons, W. Martinet, A. G. Herman, J.-P. Timmermans, and G. R. Y. De Meyer The Protein Synthesis Inhibitor Anisomycin Induces Macrophage Apoptosis in Rabbit Atherosclerotic Plaques through p38 Mitogen-Activated Protein Kinase J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 856 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Croons, W. Martinet, A. G. Herman, and G. R. Y. De Meyer Differential Effect of the Protein Synthesis Inhibitors Puromycin and Cycloheximide on Vascular Smooth Muscle Cell Viability J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 824 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Croons, W. Martinet, A. G. Herman, J.-P. Timmermans, and G. R. Y. De Meyer Selective Clearance of Macrophages in Atherosclerotic Plaques by the Protein Synthesis Inhibitor Cycloheximide J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Verheye, W. Martinet, M. M. Kockx, M. W.M. Knaapen, K. Salu, J.-P. Timmermans, J. T. Ellis, D. L. Kilpatrick, and G. R.Y. De Meyer Selective Clearance of Macrophages in Atherosclerotic Plaques by Autophagy J. Am. Coll. Cardiol., February 13, 2007; 49(6): 706 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Pagano and M. J. Haurani Vascular Cell Locomotion: Osteopontin, NADPH Oxidase, and Matrix Metalloproteinase-9 Circ. Res., June 23, 2006; 98(12): 1453 - 1455. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Khurana, S. Shafi, J. Martin, and I. Zachary Vascular Endothelial Growth Factor Gene Transfer Inhibits Neointimal Macrophage Accumulation in Hypercholesterolemic Rabbits Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1074 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. I. Seye, Q. Kong, L. Erb, R. C. Garrad, B. Krugh, M. Wang, J. T. Turner, M. Sturek, F. A. Gonzalez, and G. A. Weisman Functional P2Y2 Nucleotide Receptors Mediate Uridine 5'-Triphosphate-Induced Intimal Hyperplasia in Collared Rabbit Carotid Arteries Circulation, November 19, 2002; 106(21): 2720 - 2726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. STULAK, A. LERMAN, M. R. PORCEL, J. A. CACCITOLO, J. C. ROMERO, H. V. SCHAFF, C. NAPOLI, and L. O. LERMAN Renal Vascular Function in Hypercholesterolemia Is Preserved by Chronic Antioxidant Supplementation J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1882 - 1891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. von der Leyen and V. J. Dzau Therapeutic Potential of Nitric Oxide Synthase Gene Manipulation Circulation, June 5, 2001; 103(22): 2760 - 2765. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||